Assessing pain management in total joint arthroplasty using the Detroit interventional pain assessment scale-A prospective cohort study.

IF 4.6 Q2 MATERIALS SCIENCE, BIOMATERIALS
Lauryn J Boggs, Ishan Patel, Melina Holyszko, Bryan E Little, Hussein F Darwiche, Rahul Vaidya
{"title":"Assessing pain management in total joint arthroplasty using the Detroit interventional pain assessment scale-A prospective cohort study.","authors":"Lauryn J Boggs, Ishan Patel, Melina Holyszko, Bryan E Little, Hussein F Darwiche, Rahul Vaidya","doi":"10.1186/s42836-024-00276-w","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Total joint arthroplasty (TJA) is an effective treatment for end-stage osteoarthritis, but postoperative pain has been poorly managed. The purpose of this study was to (1) assess how much narcotic medication was prescribed after TJA; (2) assess if patients were satisfied with their pain management; (3) compare these same data between total hip arthroplasty (THA)/total knee arthroplasty (TKA); (4) compare these same data between preoperative opioid users/opioid-naïve patients.</p><p><strong>Methods: </strong>An IRB-approved prospective study was conducted at a US academic joint replacement practice. Patients were evaluated by an independent observer at three weeks, three months, and six months postoperatively using the Detroit Interventional Pain Assessment (DIPA) scale. Patients verbally rated their pain with their current medication regimen as 0 (no pain), 1 (tolerable pain), or 2 (intolerable pain) on the DIPA scale. Narcotic usage was verified by the Michigan Automated Prescription System (MAPS). Patients were divided into THA, TKA, previously on opioids, and opioid-naïve groups. Provider efficiency scores reflected pain management satisfaction and were calculated as the percentage of patients reporting no pain or tolerable pain.</p><p><strong>Results: </strong>Out of 200 patients, the percentage of patients using narcotics and their daily usage (MMEs) significantly decreased from 75.5% (27.5 MMEs) at three weeks to 42.9% (5.3 MMEs) at six months (P < 0.001). In 80% of patients, narcotics taken at six months were prescribed by outside providers. Significantly fewer patients used narcotics at six months for THA (15.4%) compared to TKA (52.7%) (P < 0.021). There was a significant difference in daily narcotic usage between patients who took narcotics preoperatively (22.9 MMEs) and opioid-naïve ones (13.4 MMEs) (P < 0.001). Provider efficiency scores were best at three weeks (76.6%) and three months (70%) but declined at six months (57.2%).</p><p><strong>Conclusions: </strong>Narcotic tapering practices were observed as postoperative daily narcotic intake decreased across six months. However, outside providers prescribed 80% of narcotics at six months, necessitating a better-coordinated practice with surgeons. Patients taking preoperative narcotics experienced higher daily MME requirements than their opioid-naïve counterparts. In terms of the percentage of patients on narcotics, THA is a better procedure for tapering patients off narcotics by six months.</p>","PeriodicalId":2,"journal":{"name":"ACS Applied Bio Materials","volume":null,"pages":null},"PeriodicalIF":4.6000,"publicationDate":"2024-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11529018/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"ACS Applied Bio Materials","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1186/s42836-024-00276-w","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"MATERIALS SCIENCE, BIOMATERIALS","Score":null,"Total":0}
引用次数: 0

Abstract

Background: Total joint arthroplasty (TJA) is an effective treatment for end-stage osteoarthritis, but postoperative pain has been poorly managed. The purpose of this study was to (1) assess how much narcotic medication was prescribed after TJA; (2) assess if patients were satisfied with their pain management; (3) compare these same data between total hip arthroplasty (THA)/total knee arthroplasty (TKA); (4) compare these same data between preoperative opioid users/opioid-naïve patients.

Methods: An IRB-approved prospective study was conducted at a US academic joint replacement practice. Patients were evaluated by an independent observer at three weeks, three months, and six months postoperatively using the Detroit Interventional Pain Assessment (DIPA) scale. Patients verbally rated their pain with their current medication regimen as 0 (no pain), 1 (tolerable pain), or 2 (intolerable pain) on the DIPA scale. Narcotic usage was verified by the Michigan Automated Prescription System (MAPS). Patients were divided into THA, TKA, previously on opioids, and opioid-naïve groups. Provider efficiency scores reflected pain management satisfaction and were calculated as the percentage of patients reporting no pain or tolerable pain.

Results: Out of 200 patients, the percentage of patients using narcotics and their daily usage (MMEs) significantly decreased from 75.5% (27.5 MMEs) at three weeks to 42.9% (5.3 MMEs) at six months (P < 0.001). In 80% of patients, narcotics taken at six months were prescribed by outside providers. Significantly fewer patients used narcotics at six months for THA (15.4%) compared to TKA (52.7%) (P < 0.021). There was a significant difference in daily narcotic usage between patients who took narcotics preoperatively (22.9 MMEs) and opioid-naïve ones (13.4 MMEs) (P < 0.001). Provider efficiency scores were best at three weeks (76.6%) and three months (70%) but declined at six months (57.2%).

Conclusions: Narcotic tapering practices were observed as postoperative daily narcotic intake decreased across six months. However, outside providers prescribed 80% of narcotics at six months, necessitating a better-coordinated practice with surgeons. Patients taking preoperative narcotics experienced higher daily MME requirements than their opioid-naïve counterparts. In terms of the percentage of patients on narcotics, THA is a better procedure for tapering patients off narcotics by six months.

使用底特律介入性疼痛评估量表评估全关节置换术中的疼痛管理--前瞻性队列研究。
背景:全关节置换术(TJA)是治疗终末期骨关节炎的一种有效方法,但术后疼痛的处理却不尽人意。本研究的目的是:(1) 评估 TJA 术后麻醉药物的处方量;(2) 评估患者对疼痛管理是否满意;(3) 比较全髋关节置换术 (THA) 和全膝关节置换术 (TKA) 的相同数据;(4) 比较术前使用阿片类药物患者和未使用阿片类药物患者的相同数据:美国一家学术关节置换诊所开展了一项经 IRB 批准的前瞻性研究。术后三周、三个月和六个月时,由一名独立观察员使用底特律介入疼痛评估(DIPA)量表对患者进行评估。患者在 DIPA 量表上对其当前用药方案下的疼痛进行口头评分,分为 0 分(无痛)、1 分(可忍受疼痛)或 2 分(无法忍受疼痛)。麻醉药使用情况由密歇根自动处方系统 (MAPS) 核实。患者被分为 THA 组、TKA 组、曾使用过阿片类药物组和未使用过阿片类药物组。医护人员的效率评分反映了疼痛管理的满意度,计算方法是报告无痛或可忍受疼痛的患者比例:在 200 名患者中,使用麻醉剂的患者比例及其每日用量(MMEs)从三周时的 75.5%(27.5 MMEs)显著下降到六个月时的 42.9%(5.3 MMEs)(P 结论:在 200 名患者中,使用麻醉剂的患者比例及其每日用量(MMEs)从三周时的 75.5%(27.5 MMEs)显著下降到六个月时的 42.9%(5.3 MMEs):随着术后 6 个月内麻醉剂日摄入量的减少,麻醉剂使用量也随之减少。然而,6 个月时,80% 的麻醉药是由外来医疗人员开具的,因此有必要与外科医生进行更好的协调。与未使用阿片类药物的患者相比,术前服用麻醉药物的患者每天需要更多的 MME。就使用麻醉药物的患者比例而言,THA 是一种能让患者在六个月内逐渐停用麻醉药物的更好方法。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
ACS Applied Bio Materials
ACS Applied Bio Materials Chemistry-Chemistry (all)
CiteScore
9.40
自引率
2.10%
发文量
464
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信